07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
06/27/2025 4:05 PM | Hagan Joseph P (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2025 4:06 PM | Aker Christopher Ray (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2025 4:06 PM | Klassen Preston (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RGLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
06/27/2025 4:09 PM | Regulus Therapeutics (Issuer) Rosen Hugh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2025 4:11 PM | PAPADOPOULOS STELIOS (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2025 4:12 PM | Regulus Therapeutics (Issuer) Witz Pascale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2025 4:12 PM | RASTETTER WILLIAM H (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 8:32 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:33 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:34 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:30 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:30 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:30 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:31 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:31 AM | Regulus Therapeutics (Filer)
| Form POS AM | |
06/25/2025 8:12 AM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2025 8:14 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:16 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:16 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:17 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:18 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:18 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:18 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:19 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:19 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:19 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:20 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:20 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:21 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:21 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:24 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:24 AM | NOVARTIS AG (Filed by) Regulus Therapeutics (Subject)
| Form SC TO-T/A | |
06/25/2025 8:24 AM | Regulus Therapeutics (Subject)
| Form SC 14D9/A | |
Elon’s BIGGEST warning yet? (Ad) Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. |
06/25/2025 8:24 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:25 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:25 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:26 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 8:28 AM | Regulus Therapeutics (Filer)
| Form S-8 POS | |
06/25/2025 7:37 AM | Nasdaq Stock Market LLC (Filed by) Regulus Therapeutics (Subject)
| Form 25-NSE | |
06/23/2025 6:00 AM | Regulus Therapeutics (Subject)
| Form SC 14D9/A | |
06/23/2025 5:02 AM | NOVARTIS AG (Filed by) Regulus Therapeutics (Subject)
| Form SC TO-T/A | |
06/17/2025 5:30 AM | NOVARTIS AG (Filed by) Regulus Therapeutics (Subject)
| Form SC TO-T/A | |
06/17/2025 5:32 AM | Regulus Therapeutics (Subject)
| Form SC 14D9/A | |
05/27/2025 7:48 AM | Regulus Therapeutics (Subject)
| Form SC 14D9 | |
05/27/2025 5:56 AM | NOVARTIS AG (Filed by) Regulus Therapeutics (Subject)
| Form SC TO-T | |
05/15/2025 7:35 AM | Regulus Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025 7:23 PM | Regulus Therapeutics (Subject)
| Form SC14D9C | |
05/01/2025 4:00 PM | NOVARTIS AG (Filed by) Regulus Therapeutics (Subject)
| Form SC TO-C | |
04/30/2025 5:16 PM | Nunn Jason Raleigh (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2025 4:00 PM | NOVARTIS AG (Filed by) Regulus Therapeutics (Subject)
| Form SC TO-C | |
04/30/2025 7:27 AM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2025 7:30 AM | Regulus Therapeutics (Subject)
| Form SC14D9C | |
03/27/2025 6:15 AM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2025 4:00 PM | CALSADA CRISPINA (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 4:00 PM | Aker Christopher Ray (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 4:00 PM | BALTIMORE DAVID (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 4:00 PM | Klassen Preston (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 4:00 PM | Hagan Joseph P (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 3:14 PM | Regulus Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/15/2025 4:00 PM | Klassen Preston (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/15/2025 4:00 PM | CALSADA CRISPINA (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/15/2025 4:00 PM | Hagan Joseph P (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/15/2025 4:00 PM | Aker Christopher Ray (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 1:35 PM | DAFNA Capital Management LLC (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024 3:26 PM | Regulus Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024 3:02 PM | Regulus Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 1:02 PM | BlackRock, Inc. (Filed by) Regulus Therapeutics (Subject)
| Form SC 13G | |
08/08/2024 3:24 PM | Regulus Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024 3:18 PM | Collier Kathryn J (Reporting) Regulus Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |